Table 3 Posthoc pairwise comparison between timepoints

From: Impact of visual presentation of atherosclerotic carotid plaque on cardiovascular risk profile using mHealth technologies

 

Intervention group

Control group

 

Posthoc pairwise comparison between timepoints (t0; t2)

Posthoc pairwise comparison between timepoints (t0;t3)

Posthoc pairwise comparison between timepoints (t0; t4)

Posthoc pairwise comparison between timepoints (t4; t1)

Posthoc pairwise comparison between timepoints (t4; t2)

Posthoc pairwise comparison between timepoints (t4; t3)

LDL-C

t(120) = 3.52

padj = 0.006 dRM = 0.29

t(120) = 3.30

padj = 0.013 dRM = 0.27

t(120) = 6.27 padj < 0.001 dRM = 0.51

t(118) = 2.97 padj = 0.036 dRM = 0.31

t(118) = 3.22 padj = 0.002 dRM = 0.30

t(118) = 4.08 padj = 0.017 dRM = 0.39

Systolic blood pressure

t(120) = 5.27 padj < 0.001 dRM = 0.44

t(120) = 6.22 padj < 0.001 dRM = 0.50

t(120) = 7.20 padj < 0.001 dRM = 0.56

t(120) = 3.38 padj = 0.01

dRM = 0.27

t(120) = 3.62 padj = 0.004 dRM = 0.30

Medication adherence

t(120) = 3.17 padj = 0.02

dRM = 0.27

t(120) = 4.20 padj < 0.001 dRM = 0.34

t(120) = 4.19 padj < 0.001 dRM = 0.32

t(118) = 3.06 padj = 0.028 dRM = 0.33

Quality of life

t(120) = 2.98 padj = 0.035 dRM = 0.26

t(120) = 3.23, padj = 0.016 dRM = 0.28

t(120) = 3.64 padj = 0.004 dRM = 0.32

t(118) = 3.58 padj = 0.005 dRM = 0.31

t(118) = 3.48 padj = 0.007 dRM = 0.31

t(118) = 4.94 padj < 0.001 dRM = 0.45